TCM
IMGN

Tang Capital Management’s Immunogen Inc IMGN Stock Holding History

Tang Capital Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,199,137
Closed -$65.2M – 143
2023
Q4 		$65.2M Buy
2,199,137
+699,137
+47% +$13.9M 6.02% 2
2023
Q3 		$23.8M Buy
1,500,000
+200,000
+15% +$3.33M 3.36% 6
2023
Q2 		$24.5M Buy
1,300,000
+25,147
+2% +$297K 3.61% 4
2023
Q1 		$4.9M Hold
1,274,853
– – 0.73% 43
2022
Q4 		$6.32M Sell
1,274,853
-225,147
-15% -$1.22M 0.92% 30
2022
Q3 		$7.17M Hold
1,500,000
– – 0.88% 35
2022
Q2 		$6.75M Hold
1,500,000
– – 1.02% 25
2022
Q1 		$7.14M Hold
1,500,000
– – 1.43% 21
2021
Q4 		$11.1M Buy
+1,500,000
New +$9.32M 2.24% 11

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Tang Capital Management's IMGN Position: Q1 2024 in Review

Tang Capital Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 2,199,137 shares — an estimated $65.2M sold.

Tang Capital Management first reported a position in IMGN in Q4 2021 and held it in 9 quarters. The position peaked at $65.2M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Tang Capital Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Tang Capital Management sold 2,199,137 Immunogen Inc shares in Q1 2024, an estimated $65.2M.
  • Tang Capital Management first reported a position in Immunogen Inc in Q4 2021 and held it in 9 quarters.
  • Tang Capital Management's Immunogen Inc position peaked at $65.2M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Tang Capital Management's 13F filing for Q1 2024, filed 15 May 2024.